HomeCompareXRESF vs JNJ

XRESF vs JNJ: Dividend Comparison 2026

XRESF yields 9523.81% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XRESF wins by $34096885384495640.00M in total portfolio value
10 years
XRESF
XRESF
● Live price
9523.81%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34096885384495640.00M
Annual income
$33,406,863,634,510,780,000,000.00
Full XRESF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — XRESF vs JNJ

📍 XRESF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXRESFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XRESF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XRESF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XRESF
Annual income on $10K today (after 15% tax)
$809,523.81/yr
After 10yr DRIP, annual income (after tax)
$28,395,834,089,334,163,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, XRESF beats the other by $28,395,834,089,334,163,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XRESF + JNJ for your $10,000?

XRESF: 50%JNJ: 50%
100% JNJ50/50100% XRESF
Portfolio after 10yr
$17048442692247820.00M
Annual income
$16,703,431,817,255,390,000,000.00/yr
Blended yield
97.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XRESF
No analyst data
Altman Z
-48.7
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XRESF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXRESFJNJ
Forward yield9523.81%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$34096885384495640.00M$30.3K
Annual income after 10y$33,406,863,634,510,780,000,000.00$4,689.40
Total dividends collected$34050931359582140.00M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: XRESF vs JNJ ($10,000, DRIP)

YearXRESF PortfolioXRESF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$963,081$952,380.95$10,592$272.30+$952.5KXRESF
2$86,751,988$85,721,491.09$11,289$357.73+$86.74MXRESF
3$7,309,257,562$7,216,432,935.10$12,123$472.89+$7309.25MXRESF
4$576,061,994,112$568,241,088,520.80$13,141$629.86+$576061.98MXRESF
5$42,471,142,252,811$41,854,755,919,110.81$14,408$846.81+$42471142.24MXRESF
6$2,929,381,022,509,453$2,883,936,900,298,945.50$16,021$1,151.60+$2929381022.49MXRESF
7$189,036,367,688,831,520$185,901,929,994,746,400.00$18,122$1,588.22+$189036367688.81MXRESF
8$11,413,921,216,762,330,000$11,211,652,303,335,279,000.00$20,930$2,228.20+$11413921216762.31MXRESF
9$644,880,140,172,767,400,000$632,667,244,470,831,700,000.00$24,792$3,191.91+$644880140172767.38MXRESF
10$34,096,885,384,495,640,000,000$33,406,863,634,510,780,000,000.00$30,274$4,689.40+$34096885384495640.00MXRESF

XRESF vs JNJ: Complete Analysis 2026

XRESFStock

Xtierra Inc., a natural resource company, engages in the exploration and development of precious and base metal deposits in Mexico. It primarily explores for zinc, silver, lead, copper, gold, and mercury deposits. The company holds 100% interest in the Bilbao project located to the northwest of Mexico City in the southeastern part of the State of Zacatecas; and the Laguna silver-gold-mercury project. Xtierra Inc. is headquartered in Toronto, Canada.

Full XRESF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this XRESF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XRESF vs SCHDXRESF vs JEPIXRESF vs OXRESF vs KOXRESF vs MAINXRESF vs ABBVXRESF vs MRKXRESF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.